DWS Healthy Living NC
DE0009769851
DWS Healthy Living NC/ DE0009769851 /
NAV25/09/2024 |
Chg.+1.7700 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
366.9500EUR |
+0.48% |
reinvestment |
Equity
Worldwide
|
DWS Investment GmbH ▶ |
Stratégie d'investissement
The fund is actively managed. The fund is not managed in reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector. The objective of the investment policy is to generate long-term capital appreciation.
To achieve this, the fund invests at least 85% of its assets in shares of the MFC share class of DWS Invest ESG Healthy Living (master fund). The objective of the investment policy of DWS Invest ESG Healthy Living is to generate above-average appreciation. To achieve this objective, the fund invests predominantly in equity securities of companies in the health care and consumer health care sector. Companies that have tied up at least half of their assets in this area or generate a significant proportion, i.e., at least half, of their revenues or net income in this area are attributed to the health care or consumer health care sector. The health care sector comprises the following segments: pharmaceuticals, biotechnology, medical technology, medical devices and medical consumer goods, health care services and technology, and managed care and life science systems.
Objectif d'investissement
The fund is actively managed. The fund is not managed in reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector. The objective of the investment policy is to generate long-term capital appreciation.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Health / Pharma |
Benchmark: |
- |
Début de l'exercice: |
01/01 |
Dernière distribution: |
02/01/2018 |
Banque dépositaire: |
State Street Bank International GmbH |
Domicile: |
Germany |
Permission de distribution: |
Germany, Switzerland, Czech Republic |
Gestionnaire du fonds: |
Schweers, Oliver |
Actif net: |
324.79 Mio.
EUR
|
Date de lancement: |
10/11/1997 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
0.00% |
Frais d'administration max.: |
1.50% |
Investissement minimum: |
0.00 EUR |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
DWS Investment GmbH |
Adresse: |
Mainzer Landstraße 11-17, 60329, Frankfurt am Main |
Pays: |
Germany |
Internet: |
www.dws.de
|
Actifs
Mutual Funds |
|
99.10% |
Cash |
|
0.90% |
Branches
Healthcare |
|
99.10% |
Cash |
|
0.90% |